A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Clinical trial NCT04352595 · COMPLETED

Trial details

NCT number: NCT04352595
Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-04-24
Primary completion: 2021-02-28
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.